Anti-HMGCR positive immune-mediated necrotizing myopathy

Česká verzia

Authors: J. Vejskal; P. Potužník
Authors place of work: Neurologická klinika LF UK a FN Plzeň
Published in the journal: Cesk Slov Neurol N 2023; 86(4): 279-281
Category: Letter to Editor
doi: https://doi.org/10.48095/cccsnn2023279

Zdroje

1. Allenbach Y, Benveniste O, Stenzel W et al. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol 2020; 16 (12): 689–701. doi: 10.1038/s41584-020-00515-9.

2. Mohassel P, Mammen AL. Anti-HMGCR Myopathy. J Neuromuscul Dis 2018; 5 (1): 11–20. doi: 10.3233/JND-170282.

3. Needham M, Fabian V, Knezevic W et al. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord 2007; 17 (2): 194–200. doi: 10.1016/j.nmd.2006.10.007.

4. Horák T, Voháňka S, Tvrdíková E et al. Statiny indukovaná nekrotizující autoimunitní myopatie. Cesk Slov Neurol N 2017; 80/113 (5): 569–577. doi: 10.14735/amcsnn2017569.

5. Babu S, Li Y. Statin induced necrotizing autoimmune myopathy. J Neurol Sci 2015; 351 (1–2): 13–17. doi: 10.1016/j.jns.2015.02.042.

6. Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med 2016; 374 (7): 664–669. doi: 10.1056/ NEJMra1515161.

7. Milone M. Diagnosis and management of immune-mediated myopathies. Mayo Clin Proc 2017; 92 (5): 826–837. doi: 10.1016/j.mayocp.2016.12.025.

8. Mizuma A, Kouchi M, Netsu S et al. Paraneoplastic anti-3-hydroxy-3-methylglutary-coenzyme a reductase antibody-positive immune-mediated necrotizing myopathy in a patient with uterine cancer. Intern Med 2017; 56 (14): 1915–1918. doi: 10.2169/internalmedicine.56.8134.

9. Zámečník J. Svalová biopsie v deseti bodech. Cesk Slov Neurol N 2018; 81/114 (3): 358–361. doi: 10.14735/ amcsnn2018358